ATE326241T1 - Pharmazeutische zusammenzetzung enthaltend furosemid und conivaptan zur behandlung des kongestiven herzversagens - Google Patents

Pharmazeutische zusammenzetzung enthaltend furosemid und conivaptan zur behandlung des kongestiven herzversagens

Info

Publication number
ATE326241T1
ATE326241T1 AT01922578T AT01922578T ATE326241T1 AT E326241 T1 ATE326241 T1 AT E326241T1 AT 01922578 T AT01922578 T AT 01922578T AT 01922578 T AT01922578 T AT 01922578T AT E326241 T1 ATE326241 T1 AT E326241T1
Authority
AT
Austria
Prior art keywords
heart failure
congestive heart
conivaptan
treatment
pharmaceutical composition
Prior art date
Application number
AT01922578T
Other languages
English (en)
Inventor
Rebecca Guggemos Bakker-Arkema
Milton Lethan Pressler
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE326241T1 publication Critical patent/ATE326241T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01922578T 2000-05-03 2001-03-22 Pharmazeutische zusammenzetzung enthaltend furosemid und conivaptan zur behandlung des kongestiven herzversagens ATE326241T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20143100P 2000-05-03 2000-05-03

Publications (1)

Publication Number Publication Date
ATE326241T1 true ATE326241T1 (de) 2006-06-15

Family

ID=22745788

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01922578T ATE326241T1 (de) 2000-05-03 2001-03-22 Pharmazeutische zusammenzetzung enthaltend furosemid und conivaptan zur behandlung des kongestiven herzversagens

Country Status (19)

Country Link
EP (1) EP1280555B8 (de)
JP (1) JP2003535823A (de)
KR (1) KR20020093971A (de)
CN (1) CN1431915A (de)
AT (1) ATE326241T1 (de)
AU (1) AU2001249364A1 (de)
BR (1) BR0110566A (de)
CA (1) CA2407929C (de)
CZ (1) CZ20023587A3 (de)
DE (1) DE60119723T2 (de)
ES (1) ES2264444T3 (de)
HU (1) HUP0300632A3 (de)
IL (1) IL152590A0 (de)
MX (1) MXPA02010865A (de)
NZ (1) NZ522641A (de)
PL (1) PL358544A1 (de)
SK (1) SK15532002A3 (de)
WO (1) WO2001082920A2 (de)
ZA (1) ZA200209367B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
WO2019141575A1 (de) * 2018-01-16 2019-07-25 Bayer Aktiengesellschaft Unterstützung bei der behandlung von herzinsuffizienz
KR20220052561A (ko) 2020-10-21 2022-04-28 장영진 어류 가공물 및/또는 콩 가공물을 유효성분으로 포함하는 심부전의 예방 또는 치료용 약학 조성물

Also Published As

Publication number Publication date
EP1280555B8 (de) 2006-06-28
ES2264444T3 (es) 2007-01-01
CZ20023587A3 (cs) 2003-06-18
KR20020093971A (ko) 2002-12-16
MXPA02010865A (es) 2003-03-27
JP2003535823A (ja) 2003-12-02
DE60119723D1 (de) 2006-06-22
WO2001082920A3 (en) 2002-07-18
EP1280555A2 (de) 2003-02-05
CA2407929C (en) 2009-05-19
HUP0300632A3 (en) 2006-02-28
CA2407929A1 (en) 2001-11-08
BR0110566A (pt) 2003-04-01
AU2001249364A1 (en) 2001-11-12
HUP0300632A2 (hu) 2003-08-28
PL358544A1 (en) 2004-08-09
ZA200209367B (en) 2004-02-18
IL152590A0 (en) 2003-05-29
NZ522641A (en) 2003-10-31
SK15532002A3 (sk) 2003-08-05
DE60119723T2 (de) 2007-04-26
CN1431915A (zh) 2003-07-23
EP1280555B1 (de) 2006-05-17
WO2001082920A2 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
TR200400238T4 (tr) ''Perindopril tert-bütilamin tuzunun alfa kristalin şekli''
NO20074657L (no) Nitrogenholdige aromatiske ringforbindelser
EP1177168A4 (de) Caspase inhibitoren und ihre verwendung
TR200001816T2 (tr) Hipolipidemik benzotiyazepin bileşikleri
MEP17108A (en) New heterocyclic compounds, their preparations and their use as medicaments, in particular as anti-bacterial agents
TNSN02022A1 (fr) Triazolopyridines anti-inflammatoires nouvelles, et compositions les contenant
NO20075376L (no) Farmasoytisk preparat og dets anvendelse
BR0013666A (pt) "alfa"-hidróxi-ácidos substituìdos inibidores de caspases e o seu uso
TNSN01046A1 (fr) Ethers de diphenyle utiles en therapeutique
EA200100184A1 (ru) Новые гидратные формы алендроната натрия, способы их получения и фармацевтические композиции
TNSN01131A1 (fr) Derives de phenoxybenzylamine nouveaux, procede pour leur preparation et compositions les contenant.
ATA16597A (de) Neue substituierte p-sulfonylaminobenzol- sulfonsäureamide
SE0102055D0 (sv) New Compounds
DE60134472D1 (de) Oxidationsverfahren zur herstellung des zwischenproduktes 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpone 17.beta.-karbonsäure
DE60119723D1 (de) Pharmazeutische zusammenzetzung enthaltend furosemid und conivaptan zur behandlung des kongestiven herzversagens
BR0015333A (pt) Derivados de isoxazol como inibidores de fosfodiesterase vii
BR9913598A (pt) Inibidores de protease de hiv
PT1280527E (pt) Utilizacao de derivados de acriloil distamicina no tratamento de tumores associados a niveis de glutationa elevados
ATE293591T1 (de) Neue n-(2-phenyl-3-aminopropyl)naphtamide
EA200101109A1 (ru) Производные 1-трифторметил-4-гидрокси-7-пиперидинил-аминометилхромана
ATE294790T1 (de) Chlormethylierung von thiophene
TNSN00095A1 (fr) Benzolactames et thioamides cycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
HK1075656A1 (en) New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds
TNSN99149A1 (fr) Nouvelles isoquinoleines, leur procede de production et compositions pharmaceutiques les contenant
TR199902117T2 (xx) (E)-4,6- Dikloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1H-�ndol-2-karboksilik asidin kristalimsi hidratlanm�� sodyum tuzu.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties